Accreditation Statement
The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Of the 1.0 credits, 0.5 have been identified as applicable to patient safety.
AMA PRA Category 1 CreditTM: 1.0
Patient Safety Credit: 0.5
Media:Journal Article, video
Release Date: 1/01/2023
Expiration Date: 1/01/2026*
Estimated time to complete this course: 1 hour
*Course access ends on course expiration date
Disclosure Policy
The American Society of Plastic Surgeons (ASPS) requires all faculty, authors, planners, reviewers, managers, staff and other individuals in a position to control or influence the content of an activity to disclose all relevant financial relationships or affiliations. All identified conflicts of interest must be resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.
Disclaimer: All relevant financial relationships for planners, faculty, and others in control of content (either individually or as a group) are reviewed by the ASPS Continuing Education Committee and have been mitigated, if applicable.
Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. Dr. Kim is a partner, Surgical Innovation Associates; Shareholder, Surgical Innovation Associates ($100,001-$200,000); Shareholder, Edge Surgical ($50,001-$100,000); Research funding, Allergan for "Breast Implants and Immune Modulation: Does implant placement promote a lasting systemic immune response capable of recognizing breast tumor associated antigens?" (Completed). None of the authors have any relevant financial relationships or affiliations to disclose. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.
Recognition Statement
The Continuing Medical Education (CME) credits offered by this activity are enhanced by ASPS Learner Credit Reporting for learners who have opted into this reporting. Successful completion of this CME activity enables active American Board of Surgery (ABS) members the opportunity to earn credit toward the CME requirement of the ABS's Continuous Certification program when claimed within 30 days of completion of the activity.
Participants in ASPS-accredited education who want their CME credits reported to certifying and state licensing boards must opt-into reporting and add their NPI as well as state license ID and/or collaborating board ID(s) before claiming credit.
Directly provided by the American Society of Plastic Surgeons® (ASPS®)